I. Introduction:
Blood transfusion forms an integral part of modern mode of therapy. Transmission of infectious diseases through donated blood is of concern to blood safety. Blood transfusion carries the risk of transfusiontransmissible infections, including HIV, hepatitis, syphilis, malaria and infrequently toxoplasmosis, and some viral infections like CMV, EBV and herpes. With every unit of blood, there is 1% chance of transfusionassociated problems including transfusion-transmitted diseases. [1] Among the TTIs, hepatitis B (HBV), hepatitis C (HCV), and HIV are the most dreadful. 2 billion people have been infected with HBV and 360 million have chronic infection worldwide and it is the 10 th leading cause of death worldwide causing 500000 to 1.2 million deaths per year due to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. [2] , [3] In Asia and most of Africa, chronic HBV infection is common and in Western countries, the disease is relatively rare. [3] Nearly 3.9 million people are estimated to be infected with HCV, the most common chronic blood-borne infection, leading to 8000 to 10000 deaths annually in USA. [4] The Indian subcontinent is classified as an intermediate HBV endemic (HBsAg carriage 2-7%) zone and has the second largest global pool of chronic HBV infections. [3] The improved screening and testing of blood donors has significantly reduced transfusion-transmitted diseases in most developed countries. This has not been so in developing nations. Poor health education and lack of awareness result in the reservoir of infections in the population.
The aim of our study was to know the seroprevalence of transfusion-transmitted infections in donors screened in blood bank in CNMCH, Kolkata.
II. Materials And Methods:
This cross-sectional observational study was done among voluntary and replacement blood donors who attended blood bank of CNMCH or blood donation camps during the period of April 2002 to March 2012. In this we included followings : (1) subjects of either sex, (2) age group (in years) -18 to 60, and (3) subjects otherwise healthy for blood donation.
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III. Results:
Among total donors (128119), male donors and female donors were 110543 & 17576 respectively. Among male donors and female donors majority, 2118(1.92%) &129(0.73%) were HBV positive respectively. Both were statistically significant (p value <0.001).
Total number of donors in age group 18-35 years and 36-60 years were 89639 & 38480 respectively. Among the age group 18-35 years HIV, HBV and Syphilis were positive in 240(0.27%), 1666(1.9%) and 286(0.32%) donors. These were statistically significant (p value<0.001). Among the age group 36-60 years HIV, HBV and Syphilis were positive in 155(0.4%), 581(1.5%) and 279(0.73%) donors. These were statistically significant (p value<0.001).
IV. Discussion:
Blood transfusion is a significant route of transmission of infectious disease like HBV, HCV, and HIV. These diseases are of great concern because they can cause fatal acute and chronic life-threatening disorders. Risk may be reduced by the vigorous screening of donors and donated blood. Prevalence of HBV, HCV, and HIV among the healthy blood donors or the replacement donors reflects the disease prevalence in the community. [5] Due to limitation in current blood screening practices in developing countries, donation by such individual is a potential threat to recipients. [6] A WHO report states that the viral dose in HIV transmission through blood is so large that one HIV positive transfusion leads to death on an average after two years in children and after three to five years in adults. [7] Blood donation collected in latent period of infection may be infectious despite of negative antibody test. [8] The report of National AIDS control organization showed a considerable increase in HIV prevalence in the year 2005 in antenatal clinic (0.5 -0.84%) and sexually transmitted diseases clinic (0.8 -2.16%) from the state of West Bengal, whereas adult HIV prevalence in the rest of the country was comparable with the previous years. [9] Seropositivity for HIV (0.28%) in this study was lower than the studies reported from other parts of India & also study done in Kolkata on 2010.
[10], [11] , [12] [5] A slow and steady increase of HIV incidence in voluntary blood donors (from 1.6 per 1000 in 1988-1989 to 3.8 per 1000 in 1996-1997) was noted in Vellore. [13] An increase in HIV incidence from 0.04 to 0.55% was shown in New Delhi between 1989 and 1995, whereas a decreasing trend of HIV incidence (0.81% in 2006, 0.32% in 2007, and 0.53% in 2008, overall 0.51%) was noted in blood donors of Bhopal and it is comparable with present study. [14] , [15] Incidence of HIV (0.16-0.18%) in Kerala remained constant from 1990 to 1999. [16] No voluntary blood donors were found to be HIV positive in Haryana. [17] In India, detection of HBV infection among blood donors is carried out by HBsAg screening, while detection of anti-HBc is rarely done. [18] In West Bengal, mandatory HCV screening started from June 2001. [5] An increasing prevalence of HBV (1.28 -1.66%), HCV (0.28 -0.35%), and HIV (0.23 -0.35%) was observed in blood donors of Kolkata in 2004 to 2005. [19] and in study done in 2010 in Kolkata where the prevalence of HBV, HCV, and HIV was 1.55%, 0.35%, and 0.32%, respectively. [5] In the present study, TTIs were maintaining nearly the same prevalence (HBV: 1.75%, HCV:0.37%, HIV: 0.28%) even in 2012.
In developed country like USA, the risk of HBV transmission through blood transfusion is 1: 63 000 units transfused. [20] Seroprevalence of HBV in other Indian studies had shown to range between 1.86 to 4.84%, which was much higher than the prevalence of the present study. [21] , [14] , [22] , [23] An increasing incidence of HBV (2.6% in 2006, 2.67% in 2007, and 3.43% in 2008 and overall -2.9%) was noted in blood donors of Bhopal. [15] Voluntary blood donors of Chandigarh had 0.66% seropositivity of HBV. [24] In different Indian studies, HCV seroprevalence ranged between 0.57 to 1.49%, which was much higher than the present study (0.35%). [16] , [21] , [14] , [15] , [24] Majority of the donors were male (86.28%), similar findings were also found in studies in different parts of India.
Seroprevalence increased after the age of 30 years, though not linearly, with the highest rate (3.2%) recorded in the 31-40 years and 51-70 years age. ; age and gender of donors seem to be important factors affecting it. [27] V. Conclusion:
In the 10-year period, 128119 donors were studied. Among them 99.96% were voluntary donors. Male donors constituted 86.28%. Seroprevalence of HIV in total donors was 0.28%. The sero-positivity of HBS Ag, HCV and syphilis was 1.75%, 0.37% and 0.44% respectively. Proper pre donation screening of blood donor and post donation testing of blood bag should be done to minimize transfusion transmitted disease. We should educate the donors as well as medical staffs and makes awareness about transfusion transmitted diseases, so that we can provide safes blood as much as and to reduce transmitted disease to recipient.
